Nivolumab +/- Ipilimumab Immunomonitoring in Metastatic Melanoma
Clinical trial NCT03225365 · COMPLETED
Trial details
- NCT number
- NCT03225365
- Sponsor
- Hospices Civils de Lyon
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-10
- Primary completion
- 2021-06-15
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.